Diagnosis and Treatment of Fetal Anemia: Eight Years Experience of a Tertiary Center

Abstract

Introduction

This study aimed to evaluate the efficacy of middle cerebral artery peak systolic velocity measurement in predicting moderate-to-severe fetal anemia and assess perinatal outcomes in patients who underwent intrauterine transfusion for fetal anemia.

Patients and Methods

A retrospective cohort of 91 pregnant women at risk of fetal anemia, delivered between 2016 and 2024, was studied. The efficacy of middle cerebral artery peak systolic velocity in predicting moderate-severe fetal anemia was assessed. Additionally, the perinatal outcomes of fetuses undergoing intrauterine transfusion were analyzed.

Results

The middle cerebral artery peak systolic velocity threshold of 1.5 multiples of the median demonstrated a sensitivity of 92.3% and a specificity of 85.7% in predicting moderate-to-severe fetal anemia before the 35th gestational week. After the 35th gestational week, sensitivity and specificity were 73.3% and 79.1%, respectively. A total of 53 intrauterine transfusion procedures were conducted on 24 patients. The survival rate among fetuses appropriately treated with intrauterine transfusion (n=22) was 68.2%, and the complication rate per procedure was 11.3%. All intrauterine and neonatal deaths (n=9) occurred in hydropic fetuses. All neonates who had undergone intrauterine transfusion were admitted to the neonatal intensive care unit for advanced care.

Conclusions

Middle cerebral artery Doppler is a valuable method for the screening and monitoring of fetal anemia, particularly before the 35th gestational week. Intrauterine transfusion should be considered the preferred treatment for moderate-to-severe fetal anemia. Given the potential risks and complications associated with intrauterine transfusion, hydropic fetuses appear to be at an elevated risk.

Keywords

doppler ultrasound - fetal anemia - middle cerebral artery - intrauterine transfusion

Publikationsverlauf

Eingereicht: 27. Dezember 2024

Angenommen nach Revision: 14. März 2025

Artikel online veröffentlicht:
10. April 2025

• References

• 1 Lindenburg IT, Van Kamp IL, Oepkes D. Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 2014; 36: 263-271
• 2 Moise KJ, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012; 120: 1132-1139
• 3 Moise KJ. Diagnosing hemolytic disease of the fetus--time to put the needles away?. N Engl J Med 2006; 355: 192-194
• 4 Mari G, Detti L, Oz U. et al. Accurate prediction of fetal hemoglobin by Doppler ultrasonography. Obstet Gynecol 2002; 99: 589-593
• 5 Martinez-Portilla R, Lopez-Felix J, Hawkins-Villareal A. et al. Performance of fetal middle cerebral artery peak systolic velocity for prediction of anemia in untransfused and transfused fetuses: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2019; 54: 722-731
• 6 Pretlove S, Fox C, Khan K. et al. Noninvasive methods of detecting fetal anaemia: a systematic review and meta-analysis. BJOG 2009; 116: 1558-1567
• 7 Mari G, Abuhamad AZ, Cosmi E. et al. Middle cerebral artery peak systolic velocity: technique and variability. J Ultrasound Med 2005; 24: 425-430
• 8 Zwiers C, Lindenburg I, Klumper F. et al. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol 2017; 50: 180-186
• 9 Lindenburg IT, Smits-Wintjens VE, van Klink JM. et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012; 206: 141.e1-8
• 10 Socol ML, MacGregor SN, Pielet BW. et al. Percutaneous umbilical transfusion in severe rhesus isoimmunization: resolution of fetal hydrops. Am J Obstet Gynecol 1987; 157: 1369-1375
• 11 Çoban A, Türkmen MK, Gürsoy T. Turkish Neonatal Society guideline to the approach, follow-up, and treatment of neonatal jaundice. Turk Pediatri Ars 2018; 53: S172
• 12 Zimmermann R, Durig P, Carpenter RJ. et al. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG 2002; 109: 746-752
• 13 Pereira L, Jenkins TM, Berghella V. Conventional management of maternal red cell alloimmunization compared with management by Doppler assessment of middle cerebral artery peak systolic velocity. Am J Obstet Gynecol 2003; 189: 1002-1006
• 14 Maisonneuve E, Jayot A, Friszer S. et al. Accuracy of middle cerebral artery Doppler assessment between 34 and 37 weeks in fetuses with red cell alloimmunization. Fetal Diagn Ther 2017; 42: 225-231
• 15 Şavkli AÖ, Çetin BA, Acar Z. et al. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation. J Obstet Gynaecol 2020; 40: 649-653
• 16 van Kamp IL, Klumper FJ, Bakkum RS. et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001; 185: 668-673
• 17 Mizuuchi M, Murotsuki J, Ishii K. et al. Nationwide survey of intrauterine blood transfusion for fetal anemia in Japan. J Obstet Gynaecol Res 2021; 47: 2076-2081
• 18 Deka D, Dadhwal V, Sharma AK. et al. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization. Arch Gynecol Obstet 2016; 293: 967-973
• 19 Tiblad E, Kublickas M, Ajne G. et al. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diag Ther 2011; 30: 266-273
• 20 Dias Z, Elayedatt RA, Karthik A. et al. Intrauterine transfusion for fetal anemia: An 8-year experience from a tertiary care center. Journal Obstet Gynecol India 2024; 1-6
• 21 Potdar O, Narkhede HR, Satoskar PR. Perinatal outcome after intrauterine transfusion in Rh isoimmunized mothers. J Obstet Gynecol India 2019; 69: 123-128